Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng, +202

The Lancet

Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma +6

MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma

Yifan Li, Bao Guan, Zhongyuan Zhang, +9

EBioMedicine

Tumor BiologyUrologyGenitourinary CancerRenal Cell CarcinomaTumor Suppressor +7

Chromobox Homolog 4 Is Correlated with Prognosis and Tumor Cell Growth in Hepatocellular Carcinoma

Boqing Wang, Jianjun Tang, Dan Liao, +10

Annals of Surgical Oncology

Tumor BiologyTumor Cell GrowthHepatologyMedicineChromobox Homolog 4 +7

Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer

Jianjun Tang, Gang Wang, Meifang Zhang, +16

Oncotarget

Tumor BiologyParadoxical RoleEpigenetic RegulationMedicineCrc Migration +10

Prognostic significance of BRCA1-associated protein 1 in colorectal cancer

Jianjun Tang, Shaoyan Xi, Gang Wang, +7

Medical Oncology

Tumor BiologyMedicinePathologyColorectal CancerCancer Genetics +2

Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance

Wei Zhao, Bo Ma, Zhihua Tian, +6

British Journal of Cancer

Lysyl oxidase assists tumor‑initiating cells to enhance angiogenesis in hepatocellular carcinoma

Min Yang, Fei Wang, Zhihua Tian, +4

International Journal of Oncology

PathologyCancer BiologyRedox BiologyTumor BiologyOxidative Stress +17

EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy

Jintian Tang, Jianghua Ou, Chunyan Xu, +9

Oncology Reports

MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6

Feng Xue, Jiwei Yin, Xu Lin, +1

Experimental and Therapeutic Medicine

GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma

Shiwen Ma, Fei Xie, Xiaohu Wen, +12

Pharmacological Research